"Sulfonic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic or organic oxy acids of sulfur which contain the RSO2(OH) radical.
| Descriptor ID |
D013451
|
| MeSH Number(s) |
D01.029.260.877.740 D01.875.800.740 D02.886.645.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sulfonic Acids".
Below are MeSH descriptors whose meaning is more specific than "Sulfonic Acids".
This graph shows the total number of publications written about "Sulfonic Acids" by people in this website by year, and whether "Sulfonic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Sulfonic Acids" by people in Profiles.
-
Surface Engineering of Graphene through Heterobifunctional Supramolecular-Covalent Scaffolds for Rapid COVID-19 Biomarker Detection. ACS Appl Mater Interfaces. 2021 Sep 15; 13(36):43696-43707.
-
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021 07 20; 118(29).
-
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. Eur J Med Chem. 2021 Oct 15; 222:113584.
-
Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model. Sci Rep. 2021 05 05; 11(1):9609.
-
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors. J Med Chem. 2022 02 24; 65(4):2848-2865.
-
N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer. J Mol Biol. 2021 06 25; 433(13):167003.
-
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun. 2021 04 01; 12(1):2016.
-
A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation. Brief Bioinform. 2021 03 22; 22(2):1476-1498.
-
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses. ACS Infect Dis. 2021 03 12; 7(3):586-597.
-
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. Antiviral Res. 2021 03; 187:105020.